Latest & greatest articles for Tinea Corporis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Tinea Corporis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Tinea Corporis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Tinea Corporis

1. Unusual Presentation of Tinea Corporis Associated With the Use of a Microneedling Device (PubMed)

Unusual Presentation of Tinea Corporis Associated With the Use of a Microneedling Device 29025223 2018 10 24 2018 12 02 1527-330X 37 7 2017 07 01 Aesthetic surgery journal Aesthet Surg J Unusual Presentation of Tinea Corporis Associated With the Use of a Microneedling Device. NP69-NP72 10.1093/asj/sjx086 da Cunha Nélia Margarida Martins NMM Dermatology Department, Hospital de Santo António dos Capuchos-Centro Hospitalar de Lisboa Central, Lisboa, Portugal. Campos Sara Leite de Azevedo SLA (...) Naphthalenes therapeutic use Needles adverse effects Rejuvenation Skin microbiology pathology Skin Aging Terbinafine Tinea diagnosis drug therapy etiology transmission 2017 10 14 6 0 2017 10 14 6 0 2018 10 26 6 0 ppublish 29025223 3868434 10.1093/asj/sjx086 PMC5846698 J Am Acad Dermatol. 2016 Feb;74(2):348-55 26549251 JAMA Dermatol. 2014 Jan;150(1):68-72 24258303 Indian Dermatol Online J. 2016 Jul-Aug;7(4):244-54 27559496 Aesthet Surg J. 2017 Jan;37(1):71-83 27530764 Aesthet Surg J. 2016 Apr;36(4):NP168-70

Full Text available with Trip Pro

2017 Aesthetic surgery journal

3. Tinea Corporis Infection - Guidelines for Prescribing Topical Antifungals

Tinea Corporis Infection - Guidelines for Prescribing Topical Antifungals Tinea Corporis Infection - Guidelines for Prescribing Topical Antifungals - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Tinea Corporis Infection - Guidelines for Prescribing Topical Antifungals Fungal or tinea infections of the skin are common, with tinea corporis (ringworm) and tinea cruris (jock itch) affecting 10 to 20% of the general population (...) at some point in their lifetime and up to 44% of wrestlers (known as tinea corporis gladiatorum) Men are more often affected than women Superficial fungal infections of the skin are caused by three dermatophytes; Trichophyton, Epidermophyton and Microsporum which use the keratin layer of the epidermis as their source of nutrition Tinea infection is classified by location on the body, not by the causative organism Tinea infections are contagious and are spread by skin-to-skin contact with infected

2017 medSask

4. Tinea corporis in a wrestling team cheerleader (PubMed)

Tinea corporis in a wrestling team cheerleader 28492027 2019 02 26 2352-6475 2 4 2016 Dec International journal of women's dermatology Int J Womens Dermatol Tinea corporis in a wrestling team cheerleader. 143-144 10.1016/j.ijwd.2016.10.001 McClanahan C C Department of Dermatology, University of Iowa. Wanat K K Department of Dermatology, University of Iowa. eng Case Reports 2016 12 06 Netherlands Int J Womens Dermatol 101654170 2352-6475 athlete cheerleader skin infection tinea tinea gladiatorum

Full Text available with Trip Pro

2016 International journal of women's dermatology

5. Topical antifungal treatments for tinea cruris and tinea corporis. (PubMed)

Topical antifungal treatments for tinea cruris and tinea corporis. Tinea infections are fungal infections of the skin caused by dermatophytes. It is estimated that 10% to 20% of the world population is affected by fungal skin infections. Sites of infection vary according to geographical location, the organism involved, and environmental and cultural differences. Both tinea corporis, also referred to as 'ringworm' and tinea cruris or 'jock itch' are conditions frequently seen by primary care (...) ), MEDLINE (from 1946), EMBASE (from 1974), and LILACS (from 1982). We also searched five trials registers, and checked the reference lists of included and excluded studies for further references to relevant randomised controlled trials. We handsearched the journal Mycoses from 1957 to 1990.Randomised controlled trials in people with proven dermatophyte infection of the body (tinea corporis) or groin (tinea cruris).Two review authors independently carried out study selection, data extraction, assessment

Full Text available with Trip Pro

2014 Cochrane

6. Luzu (luliconozole) - For the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older

Luzu (luliconozole) - For the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - LUZU (luliconazole) Cream Company: Medicis Pharmaceutical Corporation Application No.: 204153 Approval Date: 11/14/2013 Persons

2013 FDA - Drug Approval Package